Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant

US 800-774-4410
or +1-240-747-3094

Search Assistance >

Home  > Healthcare  >  Pharmaceutical  >  Drug Discovery

From Idea to Market: Product Lifecycle Management in the Pharmaceutical Industry (Market Focus)


Published Date: July 2007
Published By: Datamonitor
Page Count: 11
Order Code: R313-23917
 
DescriptionTable of ContentsSearch Inside
this Report
Similar
Products

Introduction

The pharmaceutical industry produces increasingly complex products, with reduced time-to-market windows, and stringent domestic and international regulatory and compliance requirements. Datamonitor views PLM technology as one of the most rapidly growing market due to its inherent focus on time to market and product development, key business priorities in the pharmaceutical industry.

Scope

  • Identification and analysis of the business drivers and inhibitors that are impacting PLM adoption in the pharmaceutical industry
  • Spending by Big Pharma and Biotech on PLM software and services in North America, Western Europe and APAC


  • Highlights

    Product lifecycle management will transform the drug development lifecycle process

    PLM addresses key business challenges facing the pharmaceutical industry

    Successful PLM for the pharmaceutical industry prevails over several constraining factors

    Reasons to Purchase

  • Understand and evaluate factors that will affect PLM adoption in the pharmaceutical industry
  • Align your strategy with developments in the pharmaceutical industry
  • Identify opportunities in an emerging market

  • Similar Products
    Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition
    Published Oct 2008 by Kalorama Information


    Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor types
    Published Sep 2008 by Datamonitor


    Obesity Drug Pipeline: Developing Therapies for a Complex Disease
    Published Sep 2008 by CHI Insight Pharma Reports


    Biosimilars: A viable market - but when?
    Published Sep 2008 by Espicom Healthcare Intelligence


    Commercial Insight: Inflammatory Bowel Disease - Convenience and compliance drive market success
    Published Sep 2008 by Datamonitor


    Currently Druggable in Prostate Cancer: A Drug Target Competitive Analysis
    Published Sep 2008 by BioSeeker Group AB


    Biomarkers: The Future of Next-Generation Drug R&D
    Published Sep 2008 by Takeda Pacific


    The Future of RNAi Therapeutics: Drug Pipelines and Prospects
    Published Sep 2008 by Business Insights


    Medical Nanotechnology Markets
    Published Sep 2008 by Trimark Publications


    Forecast Insight: Dyslipidemia - Genericization and negative trial data drive market shrinking
    Published Aug 2008 by Datamonitor




     


    Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
    Copyright © 1999-2008, All Rights Reserved, MindBranch.com
    Trust-e Logo
    Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
    Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
    Email: support@mindbranch.com